Status:
UNKNOWN
Using Mini Program for Self-management VS Conventional Pharmaceutical Care for Cancer Pain
Lead Sponsor:
Fujian Cancer Hospital
Conditions:
Cancer Pain
Eligibility:
All Genders
Phase:
NA
Brief Summary
With the existing medical system and insufficient medical resources in China, we developed a mini program. a pain management mini app can be useful and appreciated by patients and health care professi...
Detailed Description
Healthcare interventions delivered via personal mobile device have been shown to be acceptable to users, who have identified benefits such as convenience, access to personalized information, greater a...
Eligibility Criteria
Inclusion
- Patients aged 18 years or older;
- Be able to read Chinese and use a mobile phone;
- Histologically or cytologically confirmed solid tumor;
- Diagnosed chronic cancer pain
- Could understand the study process and evaluation, agreed to participate in the trial, and signed the informed consent form.
Exclusion
- Illiterate person;
- Incompetence;
- Inability to complete the pain assessment;
- Participation in any other therapies or other study protocols that may have an impact on pain intensity, which were the main outcomes of this study;
Key Trial Info
Start Date :
May 1 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 1 2021
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT04844645
Start Date
May 1 2021
End Date
June 1 2021
Last Update
April 14 2021
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.